Renate E. van Genugten

Glucagon-Like Peptide-1 Receptor Agonist Treatment Prevents Glucocorticoid-Induced Glucose Intolerance and Islet-Cell Dysfunction in Humans

Daniël H. van Raalte, Renate E. van Genugten, Margot M. Linssen et al. · Diabetes Care · 2011 · 147 citations · Full text

Effects of Sex and Hormone Replacement Therapy Use on the Prevalence of Isolated Impaired Fasting Glucose and Isolated Impaired Glucose Tolerance in Subjects With a Family History of Type 2 Diabetes

Renate E. van Genugten, Kristina M. Utzschneider, Jenny Tong et al. · Diabetes · 2006 · 69 citations · Full text

Family Medicine, Gynecology, Family History +17

Does dipeptidyl peptidase-4 inhibition prevent the diabetogenic effects of glucocorticoids in men with the metabolic syndrome? A randomized controlled trial

Renate E. van Genugten, Daniël H. van Raalte, Marcel H.A. Muskiet et al. · European Journal of Endocrinology · 2013 · 47 citations · Full text

The effect of alogliptin and pioglitazone combination therapy on various aspects of β-cell function in patients with recent-onset type 2 diabetes

Daniël H. van Raalte, Renate E. van Genugten, Björn Eliasson et al. · European Journal of Endocrinology · 2014 · 46 citations

Islet-cell dysfunction induced by glucocorticoid treatment: potential role for altered sympathovagal balance?

Daniël H. van Raalte, Kelly A.A. Kwa, Renate E. van Genugten et al. · Metabolism · 2012 · 32 citations

Metabolic Syndrome, Insulin Signaling, Medicine +13